Inyx, Inc. (IYXI)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Nov 7, 2025

Inyx, Inc. Company Description

Inyx, Inc., through its wholly-owned subsidiaries, operates as a specialty pharmaceutical company in the United States, Canada, and Europe.

It develops and manufactures prescription and over-the-counter pharmaceutical products. The company manufactures hydrocarbon aerosols, a delivery system for dermatological and topical drug applications; metered dose inhalers that are used for respiratory conditions; dry powdered inhalers used for respiratory ailments; metered dose nasal and throat pumps, and sprays; and sterile salines and injectables.

It focuses on research and development activities on inhalation-therapy drug delivery devices and inhalation methods, and generic prescription, and over-the-counter aerosol pharmaceutical products for respiratory, allergy, dermatological, and topical and cardiovascular applications.

The company’s proprietary products under development include generic versions of nonchlorofluorocarbon or hydrofluoroalkane single molecule and combination drug respiratory inhalants, nonCFC propelled oral sprays for cardiovascular ailments, wound irrigation, and cleansing sprays that utilize novel barrier technologies, and anti-inflammatory nasal pumps.

It also provides specialty pharmaceutical development and manufacturing consulting services to the international healthcare market.

The company was incorporated in 2000 and is based in New York, New York.

Inyx, Inc.
Inyx, Inc. logo
CountryUnited States
Founded2000
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees572

Contact Details

Address:
825 Third Avenue
New York, New York 10022
United States
Phone212-838-1111

Stock Details

Ticker SymbolIYXI
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS4618681013
SIC Code2834

Key Executives

NamePosition
Steven HandleyPresident and Director
Jay M. GreenExecutive Vice President, Director of Corporate Development and Director
Carole RichardsonCorporate Administration Manager of Inyx Pharma Ltd.
William KellyVice President of Corporate Communications and Investor Relations
Stephen BeckmanVice President of Sales and Marketing and Commercial Development